Literature DB >> 22343558

Differential expression of microRNAs in different disease states.

Maha Abdellatif1.   

Abstract

Disturbances in gene expression as a result of perturbed transcription or posttranscriptional regulation is one of the main causes of cellular dysfunction that underlies different disease states. Approximately a decade ago, the discovery of microRNAs in mammalian cells has renewed our focus on posttranscriptional regulatory mechanisms during pathogenesis. These tiny posttranscriptional regulators are differentially expressed in almost every disease that has been studied to date and can modulate expression of a gene via specifically binding to its messenger RNA. Because of their capacity to simultaneously target multiple functionally related, genes, they are proving to be potentially powerful therapeutic agents/targets. In this review, we focus on the microRNAs that are differentially regulated in the more common cardiovascular pathologies, their targets, and potential function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343558      PMCID: PMC3324925          DOI: 10.1161/CIRCRESAHA.111.247437

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  137 in total

1.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.

Authors:  Thimmaiah P Chendrimada; Richard I Gregory; Easwari Kumaraswamy; Jessica Norman; Neil Cooch; Kazuko Nishikura; Ramin Shiekhattar
Journal:  Nature       Date:  2005-06-22       Impact factor: 49.962

3.  Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.

Authors:  Y Feng; C A Gutekunst; D E Eberhart; H Yi; S T Warren; S M Hersch
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

4.  Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis.

Authors:  R T Rowland; X Meng; J C Cleveland; D R Meldrum; A H Harken; J M Brown
Journal:  J Surg Res       Date:  1997-08       Impact factor: 2.192

Review 5.  Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.

Authors:  I Pineda Torra; P Gervois; B Staels
Journal:  Curr Opin Lipidol       Date:  1999-04       Impact factor: 4.776

6.  Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5.

Authors:  Vania L F Linhares; Norma A S Almeida; Diego C Menezes; David A Elliott; Donna Lai; Eric C Beyer; Antonio C Campos de Carvalho; Mauro W Costa
Journal:  Cardiovasc Res       Date:  2004-12-01       Impact factor: 10.787

7.  BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene.

Authors:  N Watanabe; M Kurabayashi; Y Shimomura; K Kawai-Kowase; Y Hoshino; I Manabe; M Watanabe; M Aikawa; M Kuro-o; T Suzuki; Y Yazaki; R Nagai
Journal:  Circ Res       Date:  1999-07-23       Impact factor: 17.367

8.  The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.

Authors:  A Pause; S Lee; R A Worrell; D Y Chen; W H Burgess; W M Linehan; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.

Authors:  Derek J Hausenloy; A Tsang; Mihaela M Mocanu; Derek M Yellon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09-09       Impact factor: 4.733

10.  Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice.

Authors:  Nobuko Hagiwara; Michael Yeh; Ann Liu
Journal:  Dev Dyn       Date:  2007-08       Impact factor: 3.780

View more
  57 in total

Review 1.  The biology of circulating microRNAs in cardiovascular disease.

Authors:  Pil-Ki Min; Stephen Y Chan
Journal:  Eur J Clin Invest       Date:  2015-08       Impact factor: 4.686

2.  Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractility.

Authors:  Wen-Feng Cai; Guan-Sheng Liu; Chi Keung Lam; Stela Florea; Jiang Qian; Wen Zhao; Tracy Pritchard; Kobra Haghighi; Djamel Lebeche; Long Jason Lu; Jingyuan Deng; Guo-Chang Fan; Roger J Hajjar; Evangelia G Kranias
Journal:  Eur J Heart Fail       Date:  2015-07-15       Impact factor: 15.534

3.  Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.

Authors:  Xiaojian Xu; Shumin Wang; Juan Liu; Dou Dou; Limei Liu; Zhengju Chen; Liping Ye; Huixia Liu; Qiong He; J Usha Raj; Yuansheng Gao
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

4.  Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Authors:  J E Kontaraki; M E Marketou; E A Zacharis; F I Parthenakis; P E Vardas
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

Review 5.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 6.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

Review 7.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

8.  Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks.

Authors:  Paul Pang; Molly Abbott; Steven L Chang; Malyun Abdi; Nikita Chauhan; Murti Mistri; Joshua Ghofrani; Quynh-Anh Fucci; Colleen Walker; Corey Leonardi; Samuel Grady; Arvin Halim; Ryan Hoffman; Tzongshi Lu; Huixia Cao; Stefan G Tullius; Sayeed Malek; Sanjaya Kumar; Graeme Steele; Adam Kibel; Benjamin S Freedman; Sushrut S Waikar; Andrew M Siedlecki
Journal:  Kidney Int       Date:  2016-09-29       Impact factor: 10.612

9.  Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy.

Authors:  Danish Sayed; Minzhen He; Zhi Yang; Lin Lin; Maha Abdellatif
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

10.  TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling.

Authors:  Junqin Chen; Martin E Young; John C Chatham; David K Crossman; Louis J Dell'Italia; Anath Shalev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.